Adiponectin levels in myeloma patients after curcumin supplementation: A randomized clinical pilot study.

Supplementing MP regimen with 8000 mg curcumin daily for 28 days increases the serum adiponectin level after four treatment cycles in myeloma patients. This research found that myeloma patients may benefit by taking curcumin supplementation.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2025-01-01
DOI
https://doi.org/10.22088/cjim.16.2.320
Primary Topic
Curcumin's Biomedical Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Adiponectin levels in myeloma patients after curcumin supplementation: A randomized clinical pilot study.

Mika Lumban Tobing, Budi Setiawan, Ignatius Riwanto, Eko Adhi Pangarsa et al.
1 links
PubMed
Curcumin's Biomedical Applications
article

Adiponectin levels in myeloma patients after curcumin supplementation: A randomized clinical pilot study.

Mika Lumban Tobing, Budi Setiawan, Ignatius Riwanto, Eko Adhi Pangarsa, Aru Wisaksono Sudoyo, Damai Santosa, Soeharyo Hadisaputro, Suhartono Suhartono, Suyono Suyono, Catharina Suharti, Damar Mashkun Rizqi
article en

Abstract

Supplementing MP regimen with 8000 mg curcumin daily for 28 days increases the serum adiponectin level after four treatment cycles in myeloma patients. This research found that myeloma patients may benefit by taking curcumin supplementation.

PubMedVol. 16(2)
Diponegoro University (ID)
Openalex Percentile: Top 88%
Curcumin's Biomedical Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.